SFDA Approves Neusoft Mammography CAD
This article was originally published in PharmAsia News
Executive Summary
Chinese software provider Neusoft Medical System received China's State FDA certification for its proprietary mammary Computer-Aided Diagnosis (CAD) product. Industry observers note this shows local companies have the capacity to develop, manufacture and sell international-standard CAD devices designed for Asians. At present, only a few American and European countries can manufacture such sophisticated equipment. Moreover, the development of mammoCAD is based mainly on Western pathology databases, which differ from Asian characteristics and thus affect the latter's detection rate. To address this issue, Neusoft has worked with major breast cancer hospitals in Tianjin and Liaoning province to specifically tailor its product for the Asian market. (Click here for more - Chinese Language)